Interact to see
Advertisement
Advertisement
HGHRX vs PRHSX
HGHRX vs PRHSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
HGHRX vs. PRHSX commentary
Sep 08, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a Buy and PRHSX is a Buy.
FUNDAMENTALS
Fundamentals
PRHSX has more cash in the bank: 11.1B vs. HGHRX (767M). PRHSX pays higher dividends than HGHRX: PRHSX (0.01) vs HGHRX (0.00). HGHRX was incepted earlier than PRHSX: HGHRX (19 years) vs PRHSX (30 years). HGHRX (1.63) is less costly to investors than PRHSX (0.80). PRHSX is a more actively managed with annual turnover of: 52.40 vs. HGHRX (40.00). HGHRX has a lower initial minimum investment than PRHSX: HGHRX (0) vs PRHSX (2500). HGHRX (-19.19) and PRHSX (-19.37) have marching annual gain over last year. PRHSX return over 5 years is better than : -8.85 vs. HGHRX (-18.19).
| HGHRX | PRHSX | HGHRX / PRHSX | |
| Total Expense Ratio | 1.63 | 0.80 | 204% |
| Annual Report Gross Expense Ratio | 1.63 | 0.80 | 204% |
| Fund Existence | 19 years | 30 years | - |
| Gain YTD | -2.822 | 1.534 | -184% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 767M | 11.1B | 7% |
| Annual Yield % from dividends | 0.00 | 0.01 | - |
| Returns for 1 year | -19.19 | -19.37 | 99% |
| Returns for 3 years | 1.20 | -7.05 | -17% |
| Returns for 5 years | -18.19 | -8.85 | 206% |
| Returns for 10 years | -15.67 | 2.05 | -764% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers